BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15225252)

  • 1. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood].
    Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
    Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
    Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells.
    Bonanno G; Mariotti A; Procoli A; Corallo M; Rutella S; Pessina G; Scambia G; Mancuso S; Pierelli L
    Transfusion; 2007 Feb; 47(2):280-9. PubMed ID: 17302775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration.
    Eichler H; Kern S; Beck C; Zieger W; Klüter H
    Stem Cells; 2003; 21(2):208-16. PubMed ID: 12634417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term culture and identification of CD133⁺ hematopoietic progenitor cells from human umbilical cord blood].
    Wu XJ; Chen F; Lu YX; Yang H; Peng FL; Yuan L; Liu GB; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):349-53. PubMed ID: 22445981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signal-regulated kinase signaling maintains hematopoietic repopulating activity of Lin-CD34+CD133+ cord blood cells.
    Oostendorp RA; Gilfillan S; Parmar A; Schiemann M; Marz S; Niemeyer M; Schill S; Hammerschmid E; Jacobs VR; Peschel C; Götze KS
    Stem Cells; 2008 Aug; 26(8):2164-72. PubMed ID: 18499891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells.
    Ratajczak J; Zuba-Surma E; Klich I; Liu R; Wysoczynski M; Greco N; Kucia M; Laughlin MJ; Ratajczak MZ
    Leukemia; 2011 Aug; 25(8):1278-85. PubMed ID: 21483440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
    Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
    Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.